Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks yorky. I can't see anything on their website that connects to DNAP.
Even so, I'm hoping that DNAPs ancestry test will be used in the upcoming special on the tube.
best of luck
jack
Looks like a separate company. ann441j
may have jumped the gun a bit....I'd be happy to be wrong, though.
best of luck
jack
Great catch!!
best of luck
jack
Here are some other companies that have had the same regulation applied to them.
http://investor.hp.com/EdgarDetail.cfm?CIK=714154&FID=912057-02-19051&SID=02-00
(now HP)
http://www.investquest.com/iq/h/hban/fin/other/hban1512.txt
http://www.sec.gov/Archives/edgar/data/1127354/000114420405011014/v016063_form15.htm
(last trade $32)
http://www.irconnect.com/mc/secfilings.mc?cmd=disp&id=3597276&type=HTML
see http://finance.yahoo.com/q/pr?s=AMXC for current prices
Sadly, I have not gleaned any insight at all as to how or even IF any of this applies to DNAP.
best of luck
jack
From http://www.dnaprint.com/pr_9.html
"SARASOTA, Fla.--(BUSINESS WIRE)--Oct. 17, 2000
DNAPrint genomics, Inc., (Pink Sheets:DNAP), today announced that it has merged with an SEC 12g full reporting company, SDE Holdings 1, Inc., after acquiring all of the issued and outstanding stock of SDE. The merger allows DNAPrint genomics, Inc. to file its 211 application with the NASD as a successor full reporting company to become listed on the OTC Bulletin Board. DNAPrint expects to file its 8-k 12g3 within the next few days, and will apply to the NASD immediately after that filing. "
SDE Holdings 1 apparently does not exist any longer. Looks like a bookkeeping/cleaning procedure.
best of luck
jack
Fascinating article, CLF. If DNAP has the horsepower to enhance and hopefully make a better EPO, we are all in for a wild ride.
best of luck
jack
Yes, I saw this yesterday, but since there was no date, I didn't attach any relevence to it. Is dnap REALLY in a quiet period?
best of luck
jack
hmmmm...
jc
"We think too small, like the frog at the bottom of the well. He thinks the sky is only as big as the top of the well. If he surfaced, he would have an entirely different view."
best of luck
jack
From their site-
"
ReliaGene prides itself on providing the highest level of quality assurance by following strict procedures which meet or exceed industry standards. ReliaGene is accredited and/or certified by the following agencies:
American Society of Crime Lab Directors/Laboratory Accreditation Board (ASCLD/LAB) in the discipline of DNA.
American Association of Blood Banks (AABB)- Parentage Testing Committee.
National Forensic Science Technology Center (NFSTC) for compliance with the Quality Standards of the DNA Advisory Board.
The College of American Pathologists (CAP).
The Department of Health & Human Services for Clinical Laboratory Improvement Amendments (CLIA) to accept human specimens for the purpose of performing laboratory examinations.
The State of New York Department of Health for Forensic Identity, Paternity/Identity Testing and Limited DNA Testing. "
They are accredited.
best of luck
jc
DNAPrint(TM) Announces Coverage by JM Dutton
Wednesday June 9, 12:22 pm ET
SARASOTA, Fla., June 9 /PRNewswire-FirstCall/ -- DNAPrint(TM) (the "Company") announces that it is being covered by JM Dutton Associates. The JM Dutton report can be found by visiting JM Dutton at http://www.duttonassociates.com . The report is an extensive, independent analysis of the Company and its technology. The report, written by Sherry Grisewood, CFA, one of JM Dutton's senior analysts, covers all aspects of DNAPrint(TM), its technology and markets.
"We are pleased to be covered by JM Dutton Associates. It is an independent review that reinforces what I saw at DNAPrint(TM) when I was invited to join the board of directors and then lead the Company as its Chief Executive Officer and President," said Richard Gabriel, CEO and President of DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP - News). "Over the last year, we have been reorganizing and strengthening our Company with much-needed cash flow. There is no doubt that DNAPrint has been on the cutting edge of the genomics revolution, proving that you don't need to burn hundreds of millions of dollars to build a technology foothold in an emerging market. What you do need is a dedicated team of smart researchers and managers, committed to the health and success of the Company. We are beginning to emerge from a very difficult period in the Company's development, and we are aggressively seeking opportunities to put our capital to work. What our shareholders should realize is that our recent capital raising transaction is well within line of what a traditional Venture Capital deal would take in terms of equity dilution. We are doing everything we can to help boost our shareholders' confidence and build real underlying stock values."
"Ms. Grisewood's independent assessment of our technology and our position in the market is spot on," said Dr. Tony Frudakis, Chief Scientific Officer and founder of DNAPrint genomics. "It's confirmation that what we discovered, invented and were the first to put into the marketplace -- products and services that customers could actually use -- is just the beginning of what DNAPrint(TM) can bring to the table for its customers, employees and shareholders. We are pleased that someone else has looked at our Company and confirmed in a report some of the things we as management know about DNAPrint(TM)."
JM Dutton & Associates has started coverage of DNAPrint genomics, Inc. (DNAP) with its rating maintained at Speculative Buy and a price target of $0.06. The 7-page report by JM Dutton senior analyst Sherry Grisewood, CFA, is available at http://www.jmdutton.com as well as from First Call, Bloomberg, Zacks, Multex and other leading financial portals.
best of luck
jack
here's a modest complaint from Rootsweb that's music to my ears -
"I do agree with you on the lack of competition in this area--reminds me a bit of Microsoft."
Lucy Hubrich
What a horrible thing to say!
best of luck
jc
Steve Johnson, Police Administrator ILAPD, Scientific Investigation Division
555 Ramirez Street, Space 270
Los Angeles, California 90012
Telephone Number: (213) 847-0031
Fax Number:(213) 847-0036
E-mail: B8467@lapd.lacity.org
Wish I had time to change his mind.
best of luck
jack
Another story with DNAPrint involved.
http://www.winchesterstar.com/TheWinchesterStar/031231/Area_woman.asp
best of luck
jack
You could be absolutely correct. However, DNAP's forensic achievements would be a much-sought-after additional value to any DNA forensic company. Anyway, it seems that way to me.
Problem is, that without confirmation one way or the other, we are left with only speculation for now.
best of luck
jack
We need to know if Orchid and DNAP have any kind of partnership in this endeavor.
best of luck
jack
Here's a little more news on the same subject.
http://www.2theadvocate.com/stories/082303/new_dna001.shtml
best of luck
jack
Only as long as the sun's up.
(sorry)
best of luck
jack
What a tragedy....
From http://www.foxreno.com/news/2513543/detail.html
"The case gained notoriety not only because of the brutality of the slaying, but also because Concord police publicly named a different suspect, 32-year-old John Kahler, just days after the slaying.
But at that point Kahler had already committed suicide by jumping off the Golden Gate Bridge. Kahler was later cleared of any involvement in the murder. "
best of luck
jack
DNA Witness Used to Guide the Investigation in Trail Side Murder Case in Concord, California
October 15, 2003 10:49:00 AM ET
SARASOTA, Fla., Oct. 15 /PRNewswire-FirstCall/ -- DNAPrint genomics (OTC Bulletin Board: DNAP) today confirmed that DNA Witness, a DNA test that determines an individual's ancestral proportions, was strategically employed in the investigation of the Trail Side Murder Case in Concord, CA. Detectives used the DNA Witness test to obtain physical information about the suspect. This allowed detectives to focus on high value leads related to the suspect.
On September 26, Concord police announced the arrest of a suspect in the May 13, 2003 slaying of Kathleen Aiello Loreck. The DNA Witness analysis was completed in mid-August. According to detectives, using DNA Witness allowed them to narrow their investigation and re-weigh the value of certain leads based on the information provided by the test, revealing the suspect's ancestry.
"DNA Witness provided significant information about the suspect that we used to focus our investigation. DNA Witness is a great new tool in criminal investigations. It helped us in this case, and saved us time and money," said Sergeant Michael Finney of the Concord Police Department.
The suspect's arrest was achieved through outstanding detective work on the part of the Concord Police Department. Standard DNA testing provided a unique identifier from the crime scene DNA, but the crime scene DNA did not match any of the profiles in the FBI's CODIS database. The genetic heritage of an individual cannot be accurately inferred from standard DNA tests, but detectives continued their quest to learn about the suspect from his DNA. This search led investigators to DNAPrint genomics for a new type of DNA analysis, DNA Witness.
DNA Witness is the world's first forensic test to measure the ancestry of an individual from his DNA. DNA is commonly left at crime scenes, but until DNAPrint developed DNA Witness, no physical information could be reliably read from that DNA other than gender. Forensic validation studies of DNA Witness were performed by the San Diego Police Department Crime Lab, the National Center for Forensic Science and the Broward County, Florida Crime Lab. In July, a report in the Journal of Forensic Science provided the scientific rationale and results of studies related to DNA Witness. DNAPrint genomics has successfully determined the ancestral background of over 5,000 individuals.
"We are working with detectives, like Sgt. Finney, on cases that have gone cold or are at a standstill," said Richard Gabriel, CEO and President of DNAPrint genomics, Inc. "We encourage law enforcement officers to contact us. In this case, as in others when DNA Witness has been used, the scope of the investigation was narrowed and resources were more efficiently deployed in a multi-state manhunt. DNA Witness is proving to save time and resources by contributing valuable information about the suspect's ancestry. If there is a crime scene sample of DNA, DNA Witness could help re-direct or focus the investigation."
About DNAPrint genomics, Inc.
DNAPrint genomics Inc. uses proprietary human genome research methods to develop and sell genomic-based services. The Company introduced AncestrybyDNA in the consumer market and DNA Witness in the forensic market in 2003. DNAPrint is developing products in the pharmacogenomic market and has a disease gene discovery program. The Company is traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For more information about the company, please visit www.dnaprint.com.
All statements in this press release that are not historical are forward- looking statements within the meaning of Section 21E of the Securities Exchange Act as amended. Such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including, but not limited to, uncertainties relating to technologies, product development, manufacturing, market acceptance, cost and pricing of DNAPrint's products, dependence on collaborations and partners, regulatory approvals, competition, intellectual property of others, and patent protection and litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in DNAPrint's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based.
Media and Press Contacts
Richard Gabriel
DNAPrint Genomics, Inc.
CEO/President
(941) 366-3400
© 2003 PRNewswire
Additionally, that site (www.kerchner.com/pa-gerdna.htm) contains quite a few results from people that have taken the Ancestry test. Most of the results correlate with what people expected, although there were also some surprises.
Somebodys buyin this stuff!
best of luck
jack
Yes, it is. Go to the URL referenced in the articls and you will see the DNAPrint test for sale.
www.kerchner.com/pa-gerdna.htm
best of luck
jack
CHIME bldg. info and more
http://www.thenational.com.pg/0903/special7.htm
best of luck
jack
This could wind up being huge!
"In addition, there is a recent trend in the legal system to retroactively test DNA evidence left at crime scenes to substantiate or invalidate the previous legal defenses of incarcerated individuals. DNAPrintTM's technology could be used to screen the DNA samples and categorize them. For example, if the results of DNAPrintTM's testing shows that the DNA from the crime scene belongs to a an Indo European individual and the incarcerated individual is an African American, that DNA would have priority for STR testing because the likelihood of vindication is high. In recent years there have been more than 130 exonerations of previously convicted individuals based on DNA evidence. With the use of DNAPrintTM's DNAWITNESSTM 2.0, the length of wrongful incarceration for innocent individuals could be shortened. "
best of luck
jack
Thanks mingwan().
It seems like there may be a collaboration opportunity between Tony F's work and this "Michael W. Smith, Ph.D.
Principal Investigator, Human Genetics" from the NCI, although the NCI seems to be concentrating more on HIV than DNAP.
best of luck
jack
Followup to my previous post -
Here's a page about a guy at the NCI that is doing research similar to DNAP.
http://home.ncifcrf.gov/ccr/lgd/about/staff/smithm_rn.asp#chd
best of luck
jack
Thanks!
Your opinion is really, really, important to me.
best of luck
http://rex.nci.nih.gov/lgd/staff/MALD_Index.htm
Whats this?
A page in progress?
best of luck
frog- Why do you distort mjams post to convey a different meaning? Most people here, i imagine, do not have the time or inclination to read this type of romper-room, psuedo intellectualism.
It's a big board here with a lot of info that I suspect most investors would find quite interesting while not totally reliable. No need to distort or embellish someones else's post just because you can. Who's got time to read that kind of stuff?
Ah well, maybe it's just early and I haven't had my coffee yet.
best of luck
jack
There are no facts in philabels post. None at all.
Thanks w2p and Doug. What I gleaned from this article is that there is ongoing research/trials for race-specific drugs and it would seem that Ancestry would be a better method of establishing racial eligibility than self-reporting (which is the current method being employed by NitroMed, according to the article).
Back to work.
Don't know if this has been posted yet, but its interesting.
http://www.washingtonpost.com/wp-dyn/articles/A54171-2003Jul27.html
Best of luck